Research progress of spinal muscular atrophy treatment in children
M Zhao, Y Lu, N Wang, W Chen - Chinese J Contemp Neurol and …, 2018 - cjcnn.org
… splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy[…
Treatment of spinal muscular atrophy by sodium butyrate[J]. Proc Natl Acad Sci USA, 2001, …
Treatment of spinal muscular atrophy by sodium butyrate[J]. Proc Natl Acad Sci USA, 2001, …
肌病和运动神经元变性中的Matrin-3 功能障碍
C Ward, UB Pandey - 中国神经再生研究(英文版), 2022 - sjzsyj.com.cn
… the spinal cord and cerebellum, muscle atrophy, motor impairment, neuromuscular junction
… and genetic modifiers of pathogenic mutations, as well as developing model therapies. The …
… and genetic modifiers of pathogenic mutations, as well as developing model therapies. The …
肌萎缩性侧索硬化的表型异质性和神经变性的改变机制
D Oliveira, S Verjovski-Almeida, M Zatz - 中国神经再生研究(英文版), 2021 - sjzsyj.com.cn
… We were able to rule out welldescribed genetic modifiers, such as EPHA4 and UNC13A, …
protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am …
protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am …
锌指蛋白ZPR1: 拯救脊髓性肌萎缩症的运动神经元存活依赖调节剂
J Cuartas, L Gangwani - 中国神经再生研究(英文版), 2022 - sjzsyj.com.cn
… survival motor neuron protein- dependent modifier for the rescue of spinal muscular atrophy
… dependent modifier for the rescue of spinal muscular atrophy Spinal muscular atrophy (SMA…
… dependent modifier for the rescue of spinal muscular atrophy Spinal muscular atrophy (SMA…
以線蟲為模式系統探討同質多胺基酸的毒性及尋找重複序列表達修飾基因
PH Chen - 中正大學生命科學系分子生物研究所學位論文, 2016 - airitilibrary.com
… genetic modifiers required for efficient expression of expanded CTG repeats using genome-wide
RNAi approach. 13 genes … Our results showed that RNAi treatment of F11C3.1 or RFC-…
RNAi approach. 13 genes … Our results showed that RNAi treatment of F11C3.1 or RFC-…
GEMIN5 的功能和功能障碍: 了解一种新型神经发育障碍
CH Nelson, UB Pandey - 中国神经再生研究(英文版), 2024 - sjzsyj.com.cn
… in spinal muscular atrophy (SMA), … genetic modifiers may also be involved in NEDCAM
manifestation. In particular, the effects of genetic modifiers are of unique interest given their effect …
manifestation. In particular, the effects of genetic modifiers are of unique interest given their effect …
在多发性硬化症中重新利用组胺能药物
C Volonté, S Amadio - 中国神经再生研究(英文版), 2023 - sjzsyj.com.cn
… After the insurgence that is characterized by typical symptoms such as weakness in the limbs
and muscle twitches, the disease rapidly evolves into progressive muscle atrophy, paralysis…
and muscle twitches, the disease rapidly evolves into progressive muscle atrophy, paralysis…
Hippo 信号通路: 架起癌症和神经退行性疾病的桥梁
N Gogia, AV Chimata, P Deshpande, A Singh… - 中国神经再生研究 …, 2021 - sjzsyj.com.cn
… Genetic screens conducted in flies have shown Hippo as a genetic modifier of … model
reported MST1 as a key player in enhancing fast skeletal muscle atrophy. It reports …
reported MST1 as a key player in enhancing fast skeletal muscle atrophy. It reports …
[HTML][HTML] 作用于SMN2的脊髓性肌萎缩治疗药物研究进展
贺志昊, 张翔 - 药学学报, 2022 - html.rhhz.net
… hereditary neuromuscular disease, spinal muscular atrophy (… survival motor neuron 1 (SMN1)
gene. It leads to a decrease … muscle atrophy resulting in the progressive muscle weakness, …
gene. It leads to a decrease … muscle atrophy resulting in the progressive muscle weakness, …
婴儿发作性脊髓性肌萎缩症中选择性神经肌肉功能障碍的新兴概念
K Gollapalli, JK Kim, UR Monani - 中国神经再生研究(英文版), 2021 - sjzsyj.com.cn
… muscular atrophy manifests mainly as a lower motor neuron disease. Why this is so and
whether other cell types contribute to the classic spinal muscular atrophy … the modifiers in SMA …
whether other cell types contribute to the classic spinal muscular atrophy … the modifiers in SMA …